{{Rsnum
|rsid=2043556
|Gene=PRKG1
|Chromosome=10
|position=53059406
|Orientation=minus
|GMAF=0.2759
|Assembly=GRCh37
|GenomeBuild=37.1
|dbSNPBuild=131
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 65.5 | 31.9 | 2.7
| HCB | 49.3 | 42.6 | 8.1
| JPT | 57.7 | 33.3 | 9.0
| YRI | 55.1 | 40.1 | 4.8
| ASW | 66.7 | 31.6 | 1.8
| CHB | 49.3 | 42.6 | 8.1
| CHD | 58.9 | 34.6 | 6.5
| GIH | 55.4 | 36.6 | 7.9
| LWK | 54.1 | 41.3 | 4.6
| MEX | 39.7 | 41.4 | 19.0
| MKK | 57.4 | 36.8 | 5.8
| TSI | 55.9 | 34.3 | 9.8
| HapMapRevision=28
}}

{{snp near feature
| rsid = 2043556
| type = microRNA
| ACC=MI0003618
| ID=hsa-mir-605
| offset=-32
}}

{{PMID Auto
|PMID=19458495
|Title=Comprehensive analysis of the impact of SNPs and CNVs on human microRNAs and their regulatory genes.
|OA=1
}}

{{PMID Auto
|PMID=22074121
|Title=Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population.
}}

{{PMID Auto
|PMID=23613771
|Title=Polymorphisms of microRNA Sequences or Binding Sites and Lung Cancer: A Meta-Analysis and Systematic Review
|OA=1
}}

{{PMID Auto
|PMID=24413317
|Title=MicroRNA sequence polymorphisms and the risk of different types of cancer
}}
{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Affy500k}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}